Yu-Hua Li (Yuhua Li)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 22

Top Topics

Acute Myeloid Leukemia

Drug Administration

Top Venues

American journal of hematology

Journal of translational medicine

Cell death & disease

Biomarker research

This page only lists publications with an associated author ORCID identifier.

Publications

Qingyan Cen, Jianyu Chen, Jiaxin Guo, Mu Chen, Hao Wang, Suwan Wu, Honghao Zhang, Xiaoling Xie, Yu-Hua Li
CLPs-miR-103a-2-5p inhibits proliferation and promotes cell apoptosis in AML cells by targeting LILRB3 and Nrf2/HO-1 axis, regulating CD8 + T cell response. Journal of translational medicine 22 (1) (2024)
Sanfang Tu, Lijuan Zhou, Rui Huang, Xuan Zhou, Jilong Yang, Yanjie He, Yuxing Hu, Honghao Zhang, Xiaoling Xie, Yu-Hua Li
Dendritic cell vaccines extend CAR T-cell persistence and improve the efficacy of CD19 CAR T-cell therapy in refractory or relapsed adult B-ALL patients. American journal of hematology 99 (7) (2024)
Sanfang Tu, Lijuan Zhou, Rui Huang, Xuan Zhou, Jilong Yang, Yanjie He, Yuxing Hu, Honghao Zhang, Xiaoling Xie, Yu-Hua Li
Dendritic cell vaccines extend CAR T-cell persistence and improve the efficacy of CD19 CAR T-cell therapy in refractory or relapsed adult B-ALL patients. American journal of hematology 99 (7) (2024)
Qingyan Cen, Jianyu Chen, Jiaxin Guo, Mu Chen, Hao Wang, Suwan Wu, Honghao Zhang, Xiaoling Xie, Yu-Hua Li
CLPs-miR-103a-2-5p inhibits proliferation and promotes cell apoptosis in AML cells by targeting LILRB3 and Nrf2/HO-1 axis, regulating CD8 + T cell response. Journal of translational medicine 22 (1) (2024)
Sanfang Tu, Lijuan Zhou, Rui Huang, Xuan Zhou, Jilong Yang, Yanjie He, Yuxing Hu, Honghao Zhang, Xiaoling Xie, Yu-Hua Li
Dendritic cell vaccines extend CAR T-cell persistence and improve the efficacy of CD19 CAR T-cell therapy in refractory or relapsed adult B-ALL patients. American journal of hematology (2024)
Sanfang Tu, Lijuan Zhou, Rui Huang, Xuan Zhou, Jilong Yang, Yanjie He, Yuxing Hu, Honghao Zhang, Xiaoling Xie, Yu-Hua Li
Dendritic cell vaccines extend CAR T-cell persistence and improve the efficacy of CD19 CAR T-cell therapy in refractory or relapsed adult B-ALL patients. American journal of hematology 99 (7) (2024)
Qingyan Cen, Jianyu Chen, Jiaxin Guo, Mu Chen, Hao Wang, Suwan Wu, Honghao Zhang, Xiaoling Xie, Yu-Hua Li
CLPs-miR-103a-2-5p inhibits proliferation and promotes cell apoptosis in AML cells by targeting LILRB3 and Nrf2/HO-1 axis, regulating CD8 + T cell response. Journal of translational medicine 22 (1) (2024)
Qingyan Cen, Jianyu Chen, Jiaxin Guo, Mu Chen, Hao Wang, Suwan Wu, Honghao Zhang, Xiaoling Xie, Yu-Hua Li
CLPs-miR-103a-2-5p inhibits proliferation and promotes cell apoptosis in AML cells by targeting LILRB3 and Nrf2/HO-1 axis, regulating CD8 + T cell response. Journal of translational medicine 22 (1) (2024)
Xiaoling Xie, Wuju Zhang, Xuan Zhou, Binyan Xu, Hao Wang, Yingqi Qiu, Yuxing Hu, Bin Guo, Zhixin Ye, Le Hu, Honghao Zhang, Yu-Hua Li, Xiao-Chun Bai
Low doses of IFN-γ maintain self-renewal of leukemia stem cells in acute myeloid leukemia. Oncogene (2023)
Xiaoling Xie, Wuju Zhang, Min Xiao, Tiantian Wei, Yingqi Qiu, Jingyang Qiu, Hao Wang, Zeyou Qiu, Sheng Zhang, Yating Pan, Linlin Mao, Yu-Hua Li, Bin Guo, Wanwen Yang, Yuxing Hu, Shujie Hu, Yan Gong, Jun Yang, Guozhi Xiao, Yue Zhang, Xiaochun Bai
TREM2 acts as a receptor for IL-34 to suppress acute myeloid leukemia in mice. Blood (2023)
Xiaoling Xie, Wuju Zhang, Xuan Zhou, Zhixin Ye, Hao Wang, Yingqi Qiu, Yating Pan, Yuxing Hu, Luyao Li, Zhuanzhuan Chen, Wanwen Yang, Yao Lu, Shuxin Zou, Yu-Hua Li, Xiao-Chun Bai
Abemaciclib drives the therapeutic differentiation of acute myeloid leukaemia stem cells. British journal of haematology (2023)
Rong Hu, Peiyun Liao, Binyan Xu, Yingqi Qiu, Honghao Zhang, Yu-Hua Li
N6-methyladenosine RNA modifications: a potential therapeutic target for AML. Annals of hematology (2023)
Hao Wang, Yingqi Qiu, Honghao Zhang, Ning Chang, Yuxing Hu, Jianyu Chen, Rong Hu, Peiyun Liao, Zhongwei Li, Yulu Yang, Qingyan Cen, Xiangyang Ding, Meifang Li, Xiaoling Xie, Yu-Hua Li
Histone acetylation by HBO1 (KAT7) activates Wnt/β-catenin signaling to promote leukemogenesis in B-cell acute lymphoblastic leukemia. Cell death & disease 14 (8) (2023)
Yingqi Qiu, Binyan Xu, Jianhua Feng, Chunsheng Wang, Yiran Chen, Yanjie He, Xiaoling Xie, Yu-Hua Li
Loss of EPS8 sensitizes non-small-cell lung carcinoma to chemotherapy-induced DNA damage. Cancer gene therapy (2023)
Kexiu Huang, Lei Wang, Yaling Zheng, Chunyan Yue, Xuedan Xu, Hongbo Chen, Rui Huang, Yu-Hua Li
PHF6 mutation is associated with poor outcome in acute myeloid leukaemia. Cancer medicine (2022)
Yingqi Qiu, Tong Chen, Rong Hu, Ruiyi Zhu, Chujun Li, Yingchen Ruan, Xiaoling Xie, Yu-Hua Li
Next frontier in tumor immunotherapy: macrophage-mediated immune evasion. Biomarker research 9 (1) (2021)
Ming Wu, Sheng Wang, Jian-Yu Chen, Li-Juan Zhou, Zi-Wen Guo, Yu-Hua Li
Therapeutic cancer vaccine therapy for acute myeloid leukemia. Immunotherapy 13 (10) (2021)
Changlong Wang, Wei Zhang, Yanjie He, Zirui Gao, Liyuan Liu, Siyao Yu, Yuxing Hu, Shuang Wang, Chaochao Zhao, Hui Li, Jinan Shi, Wu Zhou, Feng Li, Hua Yue, Yu-Hua Li, Wei Wei, Guanghui Ma, Ding Ma
Ferritin-based targeted delivery of arsenic to diverse leukaemia types confers strong anti-leukaemia therapeutic effects. Nature nanotechnology (2021)
Yiran Chen, Xiaoling Xie, Chunsheng Wang, Yuxing Hu, Honghao Zhang, Lenghe Zhang, Sanfang Tu, Yanjie He, Yu-Hua Li
Dual targeting of NUAK1 and ULK1 using the multitargeted inhibitor MRT68921 exerts potent antitumor activities. Cell death & disease 11 (8) (2020)
Xiaoling Xie, Yuxing Hu, Tong Ye, Yiran Chen, Lijuan Zhou, Feng Li, Xiaobo Xi, Shuang Wang, Yanjie He, Xiaoyong Gao, Wei Wei, Guanghui Ma, Yu-Hua Li
Therapeutic vaccination against leukaemia via the sustained release of co-encapsulated anti-PD-1 and a leukaemia-associated antigen. Nature biomedical engineering 5 (5) (2020)
Xiaoling Xie, Yiran Chen, Yuxing Hu, Yanjie He, Honghao Zhang, Yu-Hua Li
Lenalidomide Augments the Antitumor Activities of Eps8 Peptide-Specific Cytotoxic T Lymphocytes against Multiple Myeloma. Molecular cancer therapeutics 18 (12) (2019)
Xiaoling Xie, Weijun Zhou, Yuxing Hu, Yiran Chen, Honghao Zhang, Yu-Hua Li
A dual-function epidermal growth factor receptor pathway substrate 8 (Eps8)-derived peptide exhibits a potent cytotoxic T lymphocyte-activating effect and a specific inhibitory activity. Cell death & disease 9 (3) (2018)